EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. Fate Therapeutics, Inc. Transaction History

EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:

$1.52M
portfolio value

EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:

-9.56%
quarter

Fate Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +46.24% 21.52K shares 373K $22.41 68.08K
Q2 2022 share Decrease -70.24% -109.90K shares -4.91M $24.78 46.55K
Q1 2022 share Increase +21.10% 27.26K shares -1.49M $38.77 156.45K
Q4 2021 share Increase 0.00% 129.19K shares 7.56M $60.07 129.19K